Active, not recruiting
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
NCT06100874
- Conditions
- Breast Cancer Female, Breast Cancer Metastatic, Breast Diseases, +6 more
- Locations
-
- Miami Cancer Institute at Baptist Health Miami, Florida, United States
- Dana Farber Cancer Institite Boston, Massachusetts, United States
- DFCI @ South Shore Hospital South Weymouth, Massachusetts, United States
- SCRI Oncology Partners Nashville, Tennessee, United States